Designing and conducting cost-effectiveness analyses in medicine and health care:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
San Francisco
Jossey-Bass
2002
|
| Ausgabe: | 1. ed. |
| Schlagworte: | |
| Online-Zugang: | Contributor biographical information Publisher description Table of contents Inhaltsverzeichnis |
| Beschreibung: | Includes bibliographical references (p. 335-339) and index |
| Beschreibung: | xxvi, 356 S. graph. Darst. 25 cm |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV021248071 | ||
| 003 | DE-604 | ||
| 005 | 20060522 | ||
| 007 | t | ||
| 008 | 051130s2002 xxud||| |||| 00||| eng d | ||
| 010 | |a 2002016112 | ||
| 020 | |z 0787960136 |c alk. paper |9 0-7879-6013-6 | ||
| 035 | |a (OCoLC)48858294 | ||
| 035 | |a (DE-599)BVBBV021248071 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-19 | ||
| 050 | 0 | |a RA410.5 | |
| 082 | 0 | |a 338.4/33621 |2 21 | |
| 084 | |a QX 700 |0 (DE-625)142186: |2 rvk | ||
| 100 | 1 | |a Muennig, Peter |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Designing and conducting cost-effectiveness analyses in medicine and health care |c Peter Muennig |
| 250 | |a 1. ed. | ||
| 264 | 1 | |a San Francisco |b Jossey-Bass |c 2002 | |
| 300 | |a xxvi, 356 S. |b graph. Darst. |c 25 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references (p. 335-339) and index | ||
| 650 | 4 | |a Soins médicaux - Coût - États-Unis | |
| 650 | 4 | |a Soins médicaux - États-Unis - Coût-efficacité | |
| 650 | 4 | |a aMedical care |a zUnited States |a xCost effectiveness | |
| 650 | 4 | |a aMedical care, Cost of |a zUnited States | |
| 650 | 0 | 7 | |a Gesundheitswesen |0 (DE-588)4020775-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Gesundheitswesen |0 (DE-588)4020775-4 |D s |
| 689 | 0 | 2 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 856 | 4 | |u http://www.loc.gov/catdir/bios/wiley043/2002016112.html |3 Contributor biographical information | |
| 856 | 4 | |u http://www.loc.gov/catdir/description/wiley036/2002016112.html |3 Publisher description | |
| 856 | 4 | |u http://www.loc.gov/catdir/toc/wiley022/2002016112.html |3 Table of contents | |
| 856 | 4 | 2 | |m SWB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014569519&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-014569519 | ||
Datensatz im Suchindex
| _version_ | 1804135015799324672 |
|---|---|
| adam_text | CONTENTS ACKNOWLEDGMENTS XIII LIST OF TABLES, FIGURES, AND EXHIBITS XV
TABLES XV FIGURES XIX EXHIBITS XXI PREFACE XXIII HOW TO USE THIS BOOK
XXIV A NOTE ON METHODS XXV 1 INTRODUCTION TO COST-EFFECTIVENESS 1 WHAT
IS COST-EFFECTIVENESS ANALYSIS? 1 ELEMENTS OF COST-EFFECTIVENESS
ANALYSIS * WHY CONDUCT COST-EFFECTIVENESS ANALYSIS? S SCOPE AND AIMS OF
COST-EFFECTIVENESS ANALYSIS COST-EFFECTIVENESS ANALYSIS AND POLICY 8
MAKING COMPARISONS ACROSS DISEASES * DO COST-EFFECTIVENESS ANALYSES LEAD
TO POLICY CHANGES? PRINCIPLES OF COST-EFFECTIVENESS ANALYSIS 10 THE
PERSPECTIVE OF A COST-EFFECTIVENESS ANALYSIS * THE COST-EFFECTIVENESS
RATIO * THE NUMERATOR OF THE COST-EFFECTIVENESS RATIO * THE DENOMINATOR
OF THE COST-EFFECTIVENESS EQUATION * ALLOCATING COSTS IN THE
COST-EFFECTIVENESS RATIO * INTERPRETING THE COST-EFFECTIVENESS RATIO *
COMPARING INTERVENTIONS * DEFINING THE COMPARATOR * INTERPRETING
INCREMENTAL CHANGES IN COST AND EFFECTIVENESS VIII CONTENTS OTHER TYPES
OF ANALYSES 28 COST-EFFECTIVENESS VERSUS COST-UTILITY ANALYSIS *
COST-BENEFIT ANALYSIS * COST-MINIMIZATION ANALYSIS * BURDEN OF DISEASE
ANALYSIS 2 DEVELOPING A RESEARCH PROJECT 33 THE TEN STEPS TO A PERFECT
RESEARCH PROJECT 33 DEVELOPING A RESEARCH QUESTION 35 DESIGNING YOUR
ANALYSIS 43 STEP 1: LEARN ABOUT THE DISEASE * STEP 2: CHART OUT THE
COURSE OF THE DISEASE * STEP 3: LIST THE DATA ELEMENTS THAT YOU WILL
NEED 3 WORKING WITH DATA 50 OVERVIEW 50 REVIEW OF RATES 51 PREVALENCE
VERSUS INCIDENCE * THE RELATIONSHIP BETWEEN RISKS AND RATES * RISK OVER
A LONG PERIOD OF TIME UNDERSTANDING ERROR 56 COMMON TYPES OF ERROR *
MANAGING ERROR IN COST-EFFECTIVENESS ANALYSIS * FREQUENCY DISTRIBUTIONS
AND RANDOM ERROR CALCULATING WEIGHTED MEANS 66 EVALUATING STUDY
LIMITATIONS 67 REVIEW OF MEDICAL STUDY DESIGNS * EVALUATING THE MEDICAL
LITERATURE 4 FINDING THE DATA YOU NEED 77 OVERVIEW 77 FINDING
INFORMATION IN THE MEDICAL LITERATURE 78 USING ELECTRONIC DATASETS 78
FINDING THE ELECTRONIC DATA THAT YOU NEED * WHICH DATASET SHOULD YOU
USE? * USING DATA EXTRACTION TOOLS * USING PRINTED TABULATIONS OF
ELECTRONIC DATA * UNDERSTANDING ERROR IN ELECTROINC DATA USING DATA FROM
UNPUBLISHED RESEARCH PROJECTS 88 USING DATA FROM PIGGYBACKED STUDIES 89
USING EXPERT OPINION 90 ORGANIZING YOUR DATA 90 SUMMARIZING JOURNAL
ARTICLES * SUMMARIZING DATA 5 WORKING WITH PROBABILITIES 96 OVERVIEW 96
INCIDENCE AND PREVALENCE 98 INCIDENCE RATE OF INFLUENZA-LIKE ILLNESS
CONTENTS IX SECONDARY TRANSMISSION OF INFECTIOUS DISEASE 104 SECONDARY
TRANSMISSION OF INFLUENZA DURATION OF ILLNESS 105 DURATION OF
INFLUENZA-LIKE ILLNESS EFFICACY AND MEASURES OF RISK 106 BIAS IN
SCREENING INTERVENTIONS EFFICACY OF STRATEGIES TO PREVENT INFLUENZA-LIKE
ILLNESS LABORATORY TEST DATA 112 LABORATORY TESTING FOR INFLUENZA
DISTRIBUTION OF DISEASE 114 DISTRIBUTION BY AGE * DISTRIBUTION BY STAGE
* DISTRIBUTION BY GENDER, RACE, AND SOCIOECONOMIC STATUS * OTHER
CONSIDERATIONS REGARDING THE DISTRIBUTION OF DISEASES * DISTRIBUTION OF
INFLUENZA-LIKE ILLNESS SECONDARY COMPLICATIONS OF ILLNESS 119 SECONDARY
COMPLICATIONS OF INFLUENZA-LIKE ILLNESS MEDICAL CARE UTILIZATION 120
RATES OBTAINED FROM ELECTRONIC DATA. . HOSPITALIZATION DATA FOR
INFLUENZA-LIKE ILLNESS * AMBULATORY CARE DATA FOR INFLUENZA-LIKE ILLNESS
SIDE EFFECTS 131 SIDE EFFECTS DUE TO VACCINATION OR TREATMENT
HEALTH-RELATED QUALITY OF LIFE SCORES 132 OBTAINING SCORES FROM
PUBLISHED LISTS * GENERATING HRQL SCORES USING INSTRUMENTS MORTALITY
DATA 133 MORTALITY AMONG PERSONS WITH INFLUENZA-ASSOCIATED CONDITIONS 6
WORKING WITH COSTS 137 OVERVIEW 137 OPPORTUNITY COSTS * THREE STEPS TO
ESTIMATING COSTS * MICRO-COSTING AND GROSS-COSTING MEASURING CHANGES IN
COSTS 143 FIXED COSTS AND VARIABLE COSTS * FRICTION COSTS AND TRANSFER
PAYMENTS USING DIAGNOSIS CODES 144 FUTURE MEDICAL COSTS 145 ADJUSTING
COSTS 146 ADJUSTING FOR INFLATION * CALCULATING COST-TO-CHARGE RATIOS *
ESTIMATING THE COST OF AMBULATORY AND LABORATORY SERVICES * DISCOUNTING
FUTURE COSTS ASSESSING THE RELEVANCY OF COST DATA 153 CONTENTS
DETERMINING WHICH COSTS TO INCLUDE 1 54 HOSPITAL AND AMBULATORY COSTS *
TIME COSTS * TRANSPORTATION COSTS SIDE EFFECTS * MEDICATION COSTS *
CAREGIVER COSTS 7 CONSTRUCTING A MODEL 167 167 INTRODUCTION TO DECISION
ANALYSIS TYPES OF DECISION ANALYSIS MODELS *. CONSTRUCTING SIMPLE
DECISION ANALYSIS MODELS BUILDING THE INFLUENZA MODEL 173 DEFINING THE
INITIAL BRANCHES * DEFINING VARIABLES IN THE DECISION ANALYSIS MODEL *
ENTERING FORMULAS INTO THE DECISION ANALYSIS MODEL * DEFINING TERMINAL
NODES * DEFINING AMBULATORY CARE NEEDS * SECONDARY COMPLICATIONS *
DEFINING ANTIBIOTIC USE AND SIDE EFFECTS * DEFINING HOSPITALIZATION
COSTS PATIENT COMPLIANCE * FINAL COSTS 8 WORKING WITH QUALITY OF LIFE
MEASURES 190 OVERVIEW 190 FRAMEWORK 190 WHO SHOULD VALUATE HRQL? 192
DERIVING HRQL SCORES 193 USING PREFERENCE-WEIGHTED GENERIC INSTRUMENTS *
HRQL SCORES GENERATED FROM LARGE HEALTH SURVEYS * USING
DISABILITY-ADJUSTED LIFE YEARS THINGS TO CONSIDER REGARDING HRQL SCORES
200 THE EFFECT OF AGE ON HRQL * THE EFFECT OF DISEASE STAGE ON HRQL *
THE EFFECT OF AN INTERVENTION ON HRQL * USE OF HRQL SCORES IN DIVERSE
POPULATIONS * DIRECT VERSUS INDIRECT HRQL SCORES 9 CALCULATING
QUALITY-ADJUSTED LIFE YEARS 203 OVERVIEW 203 USING THE LIFE TABLE METHOD
» CHARTING THE LIFETIME HEALTH PATH OF YOUR COHORT 8 USING THE SUMMATION
METHOD * USING THE DALY METHOD CALCULATING QALYS IN THE SAMPLE ANALYSIS
214 CALCULATING HRQL SCORES FOR INFLUENZA-LIKE ILLNESS * CALCULATING
YEARS OF LIFE LOST 8 CALCULATING QALYS IN THE VACCINATION ARM 8
CALCULATING QALYS IN THE TREAT- MENT ARM * INCREMENTAL
COST-EFFECTIVENESS OF EACH INTERVENTION * USING QALYS IN DECISION
ANALYSIS MODELS 10 CONDUCTING A SENSITIVITY ANALYSIS 229 OVERVIEW 229
ONE-WAY SENSITIVITY ANALYSIS 231 USING ONE-WAY SENSITIVITY ANALYSES TO
VALIDATE A MODEL QUESTIONS USING ONE-WAY SENSITIVITY ANALYSES AND LOW
VALUES ANSWERING SECONDARY DETERMINING PLAUSIBLE HIGH CONTENTS TWO-WAY
SENSITIVITY ANALYSIS 236 ANALYSIS OF INFLUENCE 238 DETERMINING THE
PLAUSIBLE RANGE OF EACH VARIABLE DIAGRAM MONTE CARLO SIMULATION 243 HOW
MONTE CARLO SIMULATIONS WORK DEFINING DISTRIBUTIONS MONTE CARLO
SIMULATION GENERATING AN INFLUENCE CONDUCTING A 11 PREPARING YOUR STUDY
FOR PUBLICATION 249 OVERVIEW 249 CONTENT AND STRUCTURE OF
COST-EFFECTIVENESS ARTICLES 250 INTRODUCTION * METHODS * RESULTS *
DISCUSSION * THE TECHNICAL APPENDIX PUBLISHING YOUR RESEARCH 256 WHAT
EDITORS WANT * CHOOSING THE APPROPRIATE JOURNAL 12 ADVANCED CONCEPTS 262
OVERVIEW 262 WORKING WITH MEASURES OF RISK 262 BAYES THEOREM GENERATING
LIFE TABLES 269 CALCULATING QALE USING PUBLISHED DATA * GENERATING QALE
USING ELECTRONIC DATA USING MARKOV MODELS 282 MARKOV STATES * HOW MARKOV
MODELS WORK * BENEFITS OF MARKOV MODELING APPENDIX ONE. SOLUTIONS TO
EXERCISES 289 CHAPTER ONE * CHAPTER THREE * CHAPTER FOUR * CHAPTER FIVE
* CHAPTER SIX * CHAPTER NINE * CHAPTER TEN APPENDIX TWO. JOURNAL
SUMMARIES 305 APPENDIX THREE. CENSUS TABLES 319 APPENDIX FOUR. HRQL
SCORES DERIVED FROM THE YEARS OF HEALTHY LIFE MEASURE 323 APPENDIX FIVE.
LIFE TABLES AND QUALITY-ADJUSTED LIFE TABLES 327 APPENDIX SIX. THE
EUROQOL INSTRUMENT 331 REFERENCES 335 THE AUTHOR 341 INDEX 343
|
| adam_txt |
CONTENTS ACKNOWLEDGMENTS XIII LIST OF TABLES, FIGURES, AND EXHIBITS XV
TABLES XV FIGURES XIX EXHIBITS XXI PREFACE XXIII HOW TO USE THIS BOOK
XXIV A NOTE ON METHODS XXV 1 INTRODUCTION TO COST-EFFECTIVENESS 1 WHAT
IS COST-EFFECTIVENESS ANALYSIS? 1 ELEMENTS OF COST-EFFECTIVENESS
ANALYSIS * WHY CONDUCT COST-EFFECTIVENESS ANALYSIS? S SCOPE AND AIMS OF
COST-EFFECTIVENESS ANALYSIS COST-EFFECTIVENESS ANALYSIS AND POLICY 8
MAKING COMPARISONS ACROSS DISEASES * DO COST-EFFECTIVENESS ANALYSES LEAD
TO POLICY CHANGES? PRINCIPLES OF COST-EFFECTIVENESS ANALYSIS 10 THE
PERSPECTIVE OF A COST-EFFECTIVENESS ANALYSIS * THE COST-EFFECTIVENESS
RATIO * THE NUMERATOR OF THE COST-EFFECTIVENESS RATIO * THE DENOMINATOR
OF THE COST-EFFECTIVENESS EQUATION * ALLOCATING COSTS IN THE
COST-EFFECTIVENESS RATIO * INTERPRETING THE COST-EFFECTIVENESS RATIO *
COMPARING INTERVENTIONS * DEFINING THE COMPARATOR * INTERPRETING
INCREMENTAL CHANGES IN COST AND EFFECTIVENESS VIII CONTENTS OTHER TYPES
OF ANALYSES 28 COST-EFFECTIVENESS VERSUS COST-UTILITY ANALYSIS *
COST-BENEFIT ANALYSIS * COST-MINIMIZATION ANALYSIS * BURDEN OF DISEASE
ANALYSIS 2 DEVELOPING A RESEARCH PROJECT 33 THE TEN STEPS TO A PERFECT
RESEARCH PROJECT 33 DEVELOPING A RESEARCH QUESTION 35 DESIGNING YOUR
ANALYSIS 43 STEP 1: LEARN ABOUT THE DISEASE * STEP 2: CHART OUT THE
COURSE OF THE DISEASE * STEP 3: LIST THE DATA ELEMENTS THAT YOU WILL
NEED 3 WORKING WITH DATA 50 OVERVIEW 50 REVIEW OF RATES 51 PREVALENCE
VERSUS INCIDENCE * THE RELATIONSHIP BETWEEN RISKS AND RATES * RISK OVER
A LONG PERIOD OF TIME UNDERSTANDING ERROR 56 COMMON TYPES OF ERROR *
MANAGING ERROR IN COST-EFFECTIVENESS ANALYSIS * FREQUENCY DISTRIBUTIONS
AND RANDOM ERROR CALCULATING WEIGHTED MEANS 66 EVALUATING STUDY
LIMITATIONS 67 REVIEW OF MEDICAL STUDY DESIGNS * EVALUATING THE MEDICAL
LITERATURE 4 FINDING THE DATA YOU NEED 77 OVERVIEW 77 FINDING
INFORMATION IN THE MEDICAL LITERATURE 78 USING ELECTRONIC DATASETS 78
FINDING THE ELECTRONIC DATA THAT YOU NEED * WHICH DATASET SHOULD YOU
USE? * USING DATA EXTRACTION TOOLS * USING PRINTED TABULATIONS OF
ELECTRONIC DATA * UNDERSTANDING ERROR IN ELECTROINC DATA USING DATA FROM
UNPUBLISHED RESEARCH PROJECTS 88 USING DATA FROM PIGGYBACKED STUDIES 89
USING EXPERT OPINION 90 ORGANIZING YOUR DATA 90 SUMMARIZING JOURNAL
ARTICLES * SUMMARIZING DATA 5 WORKING WITH PROBABILITIES 96 OVERVIEW 96
INCIDENCE AND PREVALENCE 98 INCIDENCE RATE OF INFLUENZA-LIKE ILLNESS
CONTENTS IX SECONDARY TRANSMISSION OF INFECTIOUS DISEASE 104 SECONDARY
TRANSMISSION OF INFLUENZA DURATION OF ILLNESS 105 DURATION OF
INFLUENZA-LIKE ILLNESS EFFICACY AND MEASURES OF RISK 106 BIAS IN
SCREENING INTERVENTIONS EFFICACY OF STRATEGIES TO PREVENT INFLUENZA-LIKE
ILLNESS LABORATORY TEST DATA 112 LABORATORY TESTING FOR INFLUENZA
DISTRIBUTION OF DISEASE 114 DISTRIBUTION BY AGE * DISTRIBUTION BY STAGE
* DISTRIBUTION BY GENDER, RACE, AND SOCIOECONOMIC STATUS * OTHER
CONSIDERATIONS REGARDING THE DISTRIBUTION OF DISEASES * DISTRIBUTION OF
INFLUENZA-LIKE ILLNESS SECONDARY COMPLICATIONS OF ILLNESS 119 SECONDARY
COMPLICATIONS OF INFLUENZA-LIKE ILLNESS MEDICAL CARE UTILIZATION 120
RATES OBTAINED FROM ELECTRONIC DATA. . HOSPITALIZATION DATA FOR
INFLUENZA-LIKE ILLNESS * AMBULATORY CARE DATA FOR INFLUENZA-LIKE ILLNESS
SIDE EFFECTS 131 SIDE EFFECTS DUE TO VACCINATION OR TREATMENT
HEALTH-RELATED QUALITY OF LIFE SCORES 132 OBTAINING SCORES FROM
PUBLISHED LISTS * GENERATING HRQL SCORES USING INSTRUMENTS MORTALITY
DATA 133 MORTALITY AMONG PERSONS WITH INFLUENZA-ASSOCIATED CONDITIONS 6
WORKING WITH COSTS 137 OVERVIEW 137 OPPORTUNITY COSTS * THREE STEPS TO
ESTIMATING COSTS * MICRO-COSTING AND GROSS-COSTING MEASURING CHANGES IN
COSTS 143 FIXED COSTS AND VARIABLE COSTS * FRICTION COSTS AND TRANSFER
PAYMENTS USING DIAGNOSIS CODES 144 FUTURE MEDICAL COSTS 145 ADJUSTING
COSTS 146 ADJUSTING FOR INFLATION * CALCULATING COST-TO-CHARGE RATIOS *
ESTIMATING THE COST OF AMBULATORY AND LABORATORY SERVICES * DISCOUNTING
FUTURE COSTS ASSESSING THE "RELEVANCY" OF COST DATA 153 CONTENTS
DETERMINING WHICH COSTS TO INCLUDE 1 54 HOSPITAL AND AMBULATORY COSTS *
TIME COSTS * TRANSPORTATION COSTS SIDE EFFECTS * MEDICATION COSTS *
CAREGIVER COSTS 7 CONSTRUCTING A MODEL 167 167 INTRODUCTION TO DECISION
ANALYSIS TYPES OF DECISION ANALYSIS MODELS *. CONSTRUCTING SIMPLE
DECISION ANALYSIS MODELS BUILDING THE INFLUENZA MODEL 173 DEFINING THE
INITIAL BRANCHES * DEFINING VARIABLES IN THE DECISION ANALYSIS MODEL *
ENTERING FORMULAS INTO THE DECISION ANALYSIS MODEL * DEFINING TERMINAL
NODES * DEFINING AMBULATORY CARE NEEDS * SECONDARY COMPLICATIONS *
DEFINING ANTIBIOTIC USE AND SIDE EFFECTS * DEFINING HOSPITALIZATION
COSTS PATIENT COMPLIANCE * FINAL COSTS 8 WORKING WITH QUALITY OF LIFE
MEASURES 190 OVERVIEW 190 FRAMEWORK 190 WHO SHOULD VALUATE HRQL? 192
DERIVING HRQL SCORES 193 USING PREFERENCE-WEIGHTED GENERIC INSTRUMENTS *
HRQL SCORES GENERATED FROM LARGE HEALTH SURVEYS * USING
DISABILITY-ADJUSTED LIFE YEARS THINGS TO CONSIDER REGARDING HRQL SCORES
200 THE EFFECT OF AGE ON HRQL * THE EFFECT OF DISEASE STAGE ON HRQL *
THE EFFECT OF AN INTERVENTION ON HRQL * USE OF HRQL SCORES IN DIVERSE
POPULATIONS * DIRECT VERSUS INDIRECT HRQL SCORES 9 CALCULATING
QUALITY-ADJUSTED LIFE YEARS 203 OVERVIEW 203 USING THE LIFE TABLE METHOD
» CHARTING THE LIFETIME HEALTH PATH OF YOUR COHORT 8 USING THE SUMMATION
METHOD * USING THE DALY METHOD CALCULATING QALYS IN THE SAMPLE ANALYSIS
214 CALCULATING HRQL SCORES FOR INFLUENZA-LIKE ILLNESS * CALCULATING
YEARS OF LIFE LOST 8 CALCULATING QALYS IN THE VACCINATION ARM 8
CALCULATING QALYS IN THE TREAT- MENT ARM * INCREMENTAL
COST-EFFECTIVENESS OF EACH INTERVENTION * USING QALYS IN DECISION
ANALYSIS MODELS 10 CONDUCTING A SENSITIVITY ANALYSIS 229 OVERVIEW 229
ONE-WAY SENSITIVITY ANALYSIS 231 USING ONE-WAY SENSITIVITY ANALYSES TO
VALIDATE A MODEL QUESTIONS USING ONE-WAY SENSITIVITY ANALYSES AND LOW
VALUES ANSWERING SECONDARY DETERMINING "PLAUSIBLE" HIGH CONTENTS TWO-WAY
SENSITIVITY ANALYSIS 236 ANALYSIS OF INFLUENCE 238 DETERMINING THE
PLAUSIBLE RANGE OF EACH VARIABLE DIAGRAM MONTE CARLO SIMULATION 243 HOW
MONTE CARLO SIMULATIONS WORK " DEFINING DISTRIBUTIONS MONTE CARLO
SIMULATION GENERATING AN INFLUENCE CONDUCTING A 11 PREPARING YOUR STUDY
FOR PUBLICATION 249 OVERVIEW 249 CONTENT AND STRUCTURE OF
COST-EFFECTIVENESS ARTICLES 250 INTRODUCTION * METHODS * RESULTS *
DISCUSSION * THE TECHNICAL APPENDIX PUBLISHING YOUR RESEARCH 256 WHAT
EDITORS WANT * CHOOSING THE APPROPRIATE JOURNAL 12 ADVANCED CONCEPTS 262
OVERVIEW 262 WORKING WITH MEASURES OF RISK 262 BAYES' THEOREM GENERATING
LIFE TABLES 269 CALCULATING QALE USING PUBLISHED DATA * GENERATING QALE
USING ELECTRONIC DATA USING MARKOV MODELS 282 MARKOV STATES * HOW MARKOV
MODELS WORK * BENEFITS OF MARKOV MODELING APPENDIX ONE. SOLUTIONS TO
EXERCISES 289 CHAPTER ONE * CHAPTER THREE * CHAPTER FOUR * CHAPTER FIVE
* CHAPTER SIX * CHAPTER NINE * CHAPTER TEN APPENDIX TWO. JOURNAL
SUMMARIES 305 APPENDIX THREE. CENSUS TABLES 319 APPENDIX FOUR. HRQL
SCORES DERIVED FROM THE YEARS OF HEALTHY LIFE MEASURE 323 APPENDIX FIVE.
LIFE TABLES AND QUALITY-ADJUSTED LIFE TABLES 327 APPENDIX SIX. THE
EUROQOL INSTRUMENT 331 REFERENCES 335 THE AUTHOR 341 INDEX 343 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author | Muennig, Peter |
| author_facet | Muennig, Peter |
| author_role | aut |
| author_sort | Muennig, Peter |
| author_variant | p m pm |
| building | Verbundindex |
| bvnumber | BV021248071 |
| callnumber-first | R - Medicine |
| callnumber-label | RA410 |
| callnumber-raw | RA410.5 |
| callnumber-search | RA410.5 |
| callnumber-sort | RA 3410.5 |
| callnumber-subject | RA - Public Medicine |
| classification_rvk | QX 700 |
| ctrlnum | (OCoLC)48858294 (DE-599)BVBBV021248071 |
| dewey-full | 338.4/33621 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/33621 |
| dewey-search | 338.4/33621 |
| dewey-sort | 3338.4 533621 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| edition | 1. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02181nam a2200517zc 4500</leader><controlfield tag="001">BV021248071</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20060522 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">051130s2002 xxud||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2002016112</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0787960136</subfield><subfield code="c">alk. paper</subfield><subfield code="9">0-7879-6013-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)48858294</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV021248071</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA410.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/33621</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 700</subfield><subfield code="0">(DE-625)142186:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Muennig, Peter</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Designing and conducting cost-effectiveness analyses in medicine and health care</subfield><subfield code="c">Peter Muennig</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">San Francisco</subfield><subfield code="b">Jossey-Bass</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxvi, 356 S.</subfield><subfield code="b">graph. Darst.</subfield><subfield code="c">25 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 335-339) and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Soins médicaux - Coût - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Soins médicaux - États-Unis - Coût-efficacité</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aMedical care</subfield><subfield code="a">zUnited States</subfield><subfield code="a">xCost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aMedical care, Cost of</subfield><subfield code="a">zUnited States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitswesen</subfield><subfield code="0">(DE-588)4020775-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gesundheitswesen</subfield><subfield code="0">(DE-588)4020775-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/bios/wiley043/2002016112.html</subfield><subfield code="3">Contributor biographical information</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/description/wiley036/2002016112.html</subfield><subfield code="3">Publisher description</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/toc/wiley022/2002016112.html</subfield><subfield code="3">Table of contents</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">SWB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014569519&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-014569519</subfield></datafield></record></collection> |
| geographic | USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV021248071 |
| illustrated | Illustrated |
| index_date | 2024-07-02T13:38:39Z |
| indexdate | 2024-07-09T20:33:47Z |
| institution | BVB |
| language | English |
| lccn | 2002016112 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-014569519 |
| oclc_num | 48858294 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | xxvi, 356 S. graph. Darst. 25 cm |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Jossey-Bass |
| record_format | marc |
| spelling | Muennig, Peter Verfasser aut Designing and conducting cost-effectiveness analyses in medicine and health care Peter Muennig 1. ed. San Francisco Jossey-Bass 2002 xxvi, 356 S. graph. Darst. 25 cm txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references (p. 335-339) and index Soins médicaux - Coût - États-Unis Soins médicaux - États-Unis - Coût-efficacité aMedical care zUnited States xCost effectiveness aMedical care, Cost of zUnited States Gesundheitswesen (DE-588)4020775-4 gnd rswk-swf Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Gesundheitswesen (DE-588)4020775-4 s Kosten-Nutzen-Analyse (DE-588)4032589-1 s DE-604 http://www.loc.gov/catdir/bios/wiley043/2002016112.html Contributor biographical information http://www.loc.gov/catdir/description/wiley036/2002016112.html Publisher description http://www.loc.gov/catdir/toc/wiley022/2002016112.html Table of contents SWB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014569519&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Muennig, Peter Designing and conducting cost-effectiveness analyses in medicine and health care Soins médicaux - Coût - États-Unis Soins médicaux - États-Unis - Coût-efficacité aMedical care zUnited States xCost effectiveness aMedical care, Cost of zUnited States Gesundheitswesen (DE-588)4020775-4 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd |
| subject_GND | (DE-588)4020775-4 (DE-588)4032589-1 (DE-588)4078704-7 |
| title | Designing and conducting cost-effectiveness analyses in medicine and health care |
| title_auth | Designing and conducting cost-effectiveness analyses in medicine and health care |
| title_exact_search | Designing and conducting cost-effectiveness analyses in medicine and health care |
| title_exact_search_txtP | Designing and conducting cost-effectiveness analyses in medicine and health care |
| title_full | Designing and conducting cost-effectiveness analyses in medicine and health care Peter Muennig |
| title_fullStr | Designing and conducting cost-effectiveness analyses in medicine and health care Peter Muennig |
| title_full_unstemmed | Designing and conducting cost-effectiveness analyses in medicine and health care Peter Muennig |
| title_short | Designing and conducting cost-effectiveness analyses in medicine and health care |
| title_sort | designing and conducting cost effectiveness analyses in medicine and health care |
| topic | Soins médicaux - Coût - États-Unis Soins médicaux - États-Unis - Coût-efficacité aMedical care zUnited States xCost effectiveness aMedical care, Cost of zUnited States Gesundheitswesen (DE-588)4020775-4 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd |
| topic_facet | Soins médicaux - Coût - États-Unis Soins médicaux - États-Unis - Coût-efficacité aMedical care zUnited States xCost effectiveness aMedical care, Cost of zUnited States Gesundheitswesen Kosten-Nutzen-Analyse USA |
| url | http://www.loc.gov/catdir/bios/wiley043/2002016112.html http://www.loc.gov/catdir/description/wiley036/2002016112.html http://www.loc.gov/catdir/toc/wiley022/2002016112.html http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014569519&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT muennigpeter designingandconductingcosteffectivenessanalysesinmedicineandhealthcare |